Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Images
https://upload.orthobullets.com/topic/8014/images/2a_moved.jpg
https://upload.orthobullets.com/topic/8014/images/2b_moved.jpg
https://upload.orthobullets.com/topic/8014/images/Case A - prox tibia - xray lat - Parson_moved.png
https://upload.orthobullets.com/topic/8014/images/Case E - femur shaft - xray ap - Parsons_moved.png
https://upload.orthobullets.com/topic/8014/images/Case E - femur shaft -T2 MRI - Parsons_moved.png
https://upload.orthobullets.com/topic/8014/images/Case A - prox tibia - xray ap - Parson_moved.png
https://upload.orthobullets.com/topic/8014/images/Case A - prox tibia - mri axial - Parson_moved.png
https://upload.orthobullets.com/topic/8014/images/Histology A_moved.png
  • SUMMARY
    • Conventional intramedullary osteosarcomas are malignant, aggressive, osteogenic bone tumors most commonly found in the knee and shoulder regions. Patients are typically children, teenagers or young adults who present with rapidly progressive pain and swelling.
    • Diagnosis is made with a biopsy showing malignant-appearing mesenchymal spindle cells with significant atypia, pleomorphism and mitotic figures producing lace-like woven bone (osteoid). 
    • Treatment is usually neo-adjuvant chemotherapy, limb sparing surgery (wide surgical resection and reconstruction), followed by adjuvant chemotherapy. Amputation may occasionally be required. 
  • Epidemiology
    • Incidence
      • most common type of osteosarcoma
      • incidence
        • first peak (adolescents): 7-8 cases per million
        • second peak (elderly): 4.2 cases per million
      • prevalence
        • approximately 2.4% of all pediatric cancers
  • ETIOLOGY
    • Genetics
      • most cases are sporadic and not associated with an underlying genetic predisposition or familial inheritance
      • some cases are associated with tumor suppressor genes (AD inheritance) including
        • Retinoblastoma tumor suppressor gene (Rb) predisposes to osteosarcoma
        • P53 tumor suppressor gene mutations (ie patients with Li-Fraumeni syndrome) predisposes to a high incidence of breast cancer and osteosarcoma
    • Associated conditions
      • Retinoblastoma
      • Li-Fraumeni syndrome
      • Rothmund-Thomson syndrome
        • AR inheritance, mutations in RECQL4 gene
        • sun-sensitive facial poikiloderma rash (pigmentation, thinned skin, prominent blood vessels), alopecia, juvenile cataracts, dental abnormalities
        • increased risk osteosarcoma, fibrosarcoma, gastric adenocarcinoma, cutaneous BCC and SCC
      • Bloom syndrome
        • AR inheritance, mutations in BLM gene
        • associated with UV-induced facial rash, short stature, insulin resistance, and sparse subcutaneous fat
        • increased risk of osteosarcoma, leukemia, lymphoma, GI tumors
      • Werner syndrome
        • AR inheritance, mutations in WRN gene
        • referred to as "adult progeria"
        • characterized by premature aging, osteoporosis, cataracts
        • increased risk of osteosarcoma
      • Fibrous dysplasia
        • more common in the polyostotic form
  • PRESENTATION
    • Symptoms
      • pain and swelling are the usual initial presenting symptoms
        • night pain and pain at rest are common
        • often dismissed as a sports injury
      • the median time of onset of symptoms to diagnosis is 4 months
    • Physical exam
      • inspection
        • swelling
        • palpable mass
        • tenderness to palpation over area of concern
      • motion
        • may have decreased range of motion if large soft-tissue mass is present
      • neurovascular
        • can cause nerve or vascular compression with mass effect
      • provocative tests
        • pain with axial loading if lower extremity lesion
  • CLASSIFICATION
    • Grading and Staging Classification
      • most commonly diagnosed as MSTS Stage IIB (high grade, extra-compartmental, no metastases)
        • approximately 90-95% of conventional osteosarcomas are high-grade and penetrate cortex early to form soft tissue masses 
    • Osteosarcoma Subtypes
      • Osteosarcoma Subtype Classification
      • INTRAMEDULLARY
      • High-grade
      • Conventional Osteosarcoma (this topic)
      • May consist of many different tissue types such as cartilaginous tissue, fibrous tissue, giant cells and small round blue cells; can be sub-typed accordingly
      • Telangiectatic Osteosarcoma
      • Histology is similar in appearance to aneurysmal bone cyst, with blood-filled cavities and sinusoids with scant osteoid production in the walls of the cystic cavities
      • Small-cell
      • Considered a histologic combination of Ewing sarcoma and osteosarcoma; small round blue cells with immature osteoid production
      • Low-grade
      • Fibrous dysplasia-like
      • High-volume fibrous stroma with immature osteoid production
      • Desmoplastic fibroma-like
      • Low-volume fibrous stroma with immature osteoid production
      • SURFACE
      • High-grade
      • Dedifferentiated surface
      • Intermediate-grade
      • Periosteal Osteosarcoma
      • Osteosarcoma coming from between surface of bone and inner layer of periosteum
      • Low-grade
      • Parosteal Osteosarcoma
      • Surface osteosarcoma coming from outer layer of periosteum
      • INTRACORTICAL
      • Intracortical osteosarcoma is the rarest type of bony osteosarcoma
      • EXTRASKELETAL
      • Extraskeletal is the rarest subtype (<5% of all osteosarcomas), and is generally considered a soft tissue sarcoma treated with wide resection and radiation.
  • Imaging
    • Radiographs
      • recommended views
        • AP and lateral X-rays of the entire bone
      • findings
        • medullary and cortical bony destruction
        • periosteal reaction (Codman's triangle)
        • in skeletally immature patients, most tumors do not extend past the epiphyseal plate
        • 10% present with pathologic fracture
    • CT
      • indications
        • chest CT required at presentation to evaluate for pulmonary metastases
        • CT of extremity may help detect subtle mineralization not visualized on an Xray
    • Bone scan
      • indications
        • useful to evaluate the extent of local disease and the presence of bone metastases
        • technetium Tc-99m bone scan or FDG-PET scan can identify skip lesions
      • findings
        • very hot
    • PET-CT
      • indications
        • no clear role for PET-CT imaging in osteosarcoma
        • potential uses include correlating percent necrosis to standard uptake values (SUVs) in pre- and post-chemotherapy settings to see the most metabolic portion of the lesion for optimal biopsy location
      • findings
        • can differentiate between benign and malignant pulmonary nodules depending on size
  • Diagnosis
    • Diagnosis depends on 2 histological criteria
      • tumor cells produce osteoid
      • stromal cells are frankly malignant
  • Differential
      • Osteosarcoma Differential
      • NON-NEOPLASTIC
      • Radiographic Presentation
      • Characteristic Histology
      • Treatment
      • Osteomyelitis
      • Imaging findings lag by 2 weeks; 50% bone loss before evident on plain X-ray
      • Bone lucency, sclerotic rim, osteopenia, periosteal reaction
      • May present with sequestrum, involucrum, or Brodie's abscess
      • Live osteocytes with numerous neutrophils (acute)
      • No nuclei in osteocytes with fibrosis of marrow and lymphocytic infiltrate (chronic)
      • IV antibiotics, irrigation + debridement
      • BENIGN
      • Eosinophilic granuloma
      • Most common in children ages <20 years, "great mimicker"
      • Well-defined intramedullary lytic lesions with cortical destruction and periosteal reaction
      • Metaphyseal lesions that do not cross the physis
      • Vertebra plana, hyperkyphosis
      • Multiple lytic cranial lesions
      • Langerhans cells, giant cells
      • Lack nuclear atypia and atypical mitoses
      • Observation if asymptomatic
      • Bracing (corrects deformity in 90% of patients)
      • Steroid injections (symptomatic lesions)
      • Chemotherapy (diffuse HSC)
      • MALIGNANT
      • Osteosarcoma
      • Medullary/cortical bony destruction with soft tissue mass, periosteal reaction
      • Usually mixed blastic/lytic
      • Tumor cells produce "lacey" osteoid
      • Stroma appear malignant with high nucleus-to-cytoplasm ratio, abnormal mitotic figures
      • Wide resection + chemotherapy
      • Ewing Sarcoma
      • Most common at age <20 years, peak incidence 10-15 years
      • Large destructive lesion with ill-defined, permeative, moth-eaten appearance, periosteal reaction, and associated soft tissue mass
      • Sheets of monotonous small round blue cells with high nucleus-to-cytoplasm ratio
      • Wide resection + chemotherapy
      • Dedifferentiated chondrosarcoma
      • Bimorphic appearance
      • Aggressive appearing unmineralized mass (spindle component) adjacent to a mineralized chondroid tumor, often with soft tissue mass
      • Chondrosarcoma component adjacent to high grade spindle cell component (usually osteosarcoma, fibrosarcoma, MFH) with abrupt transition between the two
      • Wide resection + chemotherapy
      • Fibrosarcoma
      • Usually older patients age >55 years
      • Ill-defined, purely lytic lesion; permeative bone destruction resembling osteosarcoma
      • Atypical spindle cells in a herringbone pattern, resembling soft tissue sarcoma
      • Wide resection + chemotherapy
      • Rhabdomyosarcoma
      • Nonspecific soft tissue density, isointense to adjacent muscle on T1, hyperintense on T2
      • >20% with adjacent bony destruction
      • Small round blue cells (embryonal)
      • Aggregates of poorly differentiated round cells with multinucleate giant cells surrounded by dense fibrous septae (alveolar)
      • Wide resection + chemotherapy (pediatric) or radiation (adults)
      • Desmoplastic fibroma
      • Most common in ages 15-25 years
      • Purely lytic, soap-bubble appearance with endosteal scalloping
      • Possible soft tissue mass
      • Dense swirling fibrous spindle cells, mature fibroblasts without cellular atypia, abundant bundles of collagen
      • Wide resection
      • Leukemia (acute lymphoblastic)
      • Peak incidence at age 4 years
      • Diffuse osteopenia, metaphyseal bands, periosteal reaction, lytic lesions, mixed sclerosis/lysis, permeative destruction
      • Increased cellularity packed with blasts and variable number of granulocytic/monocytic cells and erythroid precursors
      • Chemotherapy
      • Lymphoma
      • Most common in ages 35-55 years
      • Ill-defined diffuse lytic lesions with mottled appearance, more common in diaphysis, "ivory" vertebrae
      • Extensive marrow involvement with large soft tissue mass
      • Mixed small round blue cell infiltrate (different sizes and shapes)
      • Diffuse infiltration of trabeculae
      • Multi-agent chemotherapy +/- local irradiation
      • Secondary sarcoma
      • Tumor-specific
      • Tumor-specific
      • Wide resection + chemotherapy
  • Technique
    • Chemotherapy
      • administration 
        • preoperative (neoadjuvant chemotherapy) given for 8-12 weeks followed by maintenance chemotherapy for 6-12 months after surgical resection
        • restage the lesion following neoadjuvant chemo (X-Ray, MRI, CT chest, Bone scan)
      • Chemotherapy Agents used to Treat Osteosarcoma
      • Mechanism
      • Side effects
      • Methotrexate
      • Inhibits DNA synthesis by inhibiting dihydrofolate reductase
      • myelosuppression; mucositis
      • Doxorubicin
      • Blocks DNA/RNA synthesis by inhibiting topoisomerase II
      • Cardiotoxicity
      • Cisplatin
      • DNA disruption by covalent binding
      • renal failure, hearing loss, neurotoxicity
      • Ifosfamide
      • DNA-alkylating agent
      • renal failure, hemorrhagic cystitis
    • Amputation 
      • technique
        • above-knee amputation 
        • below-knee amputation 
        • forequarter amputations for rare sites of presentation
    • Radiation
      • indications
        • conventional intramedullary osteosarcoma is a radioresistant tumor, therefore radiation is not indicated except in selected cases
        • extraskeletal osteosarcoma is an exception, which is radiosensitive with reduced local recurrence rates
  • COMPLICATIONS
    • Endoprosthetic reconstruction
      • Allograft or autograft fracture
        • osteoarticular allografts have notoriously been associated with early infection, fracture, joint degeneration and nonunion
      • Allograft or autograft fracture/nonunion
        • chemo, radiation, extracorporeal treatment of autograft bone are all risk factors
      • Reoperation
        • primary malignant bone tumor higher reoperation rate than benign aggressive
        • use of NPWT associated with increased reoperation rate (but not infection rate)
    • Rotationplasty
      • arteriovenous occlusion
        • requires immediate exploration
      • nonunion of the osteotomies
        • revision ORIF with augmentation
      • malrotation
        • revision ORIF with rotational correction osteotomy
      • deep infection
      • complications/ulcers with prosthetic wear
    • Amputation secondary to limb salvage failure
      • wound healing
      • contractures
      • neuroma formation
      • phantom limb symptoms
      • deep/superficial infection
  • Prognosis
    • 5-year survival
      • without detectable metastases at the initial presentation
      • with detectable metastases at initial presentation
        • patients who present with or develop pulmonary mets can often be treated with pulmonary metastatectomy
        • bone metastases are considered incurable
    • Poor prognostic factors include
      • advanced stage of disease
        • most important predictor of survival
        • ~30% 5-year survival with aggressive treatment of late (>1 year) pulmonary metastasis with thoracotomy
      • response to neoadjuvant chemotherapy
        •  judged by percent tumor necrosis of resected specimen
        • >90% necrosis is a good prognostic indicator
      • age > 40
        •  at time of diagnosis
      • males
      • tumor site and size
      • expression of P-glycoprotein
      • VEGF overexpression
      • high ALP/LDH
        • significantly high LDH on initial labs may indicate the presence of metastases
      • vascular involvement
      • positive surgical margins
flashcard locked
Create a free account or log in to see the cards.
Question
1 of 39
Pathology | Intramedullary Osteosarcoma
  • Pathology
  • - Conventional Intramedullary Osteosarcoma
12:56 min
10/16/2019
1939 plays
4.8
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
(10)
Private Note